See where medication workflows lose information, medicines and capacity. Then watch Sitora close the loop.
Three interactive product experiences show the proposition more clearly than a report: reconcile medication changes across organisations, prevent avoidable repeat supply, and identify evidence-backed opportunities to release medicines-pathway capacity.
Choose the problem. Follow the workflow. See what counts as proof.
The demos are the front door to Sitora. Start with the operational problem, then inspect the evidence and pilot design behind it.
Medicine Loop
Has every affected service acted on the same authorised medication change?
Watch a hospital-stopped medicine move across GP, pharmacy, care-home and community workflows. The loop stays open until the downstream records and actions are reconciled.
WasteGuard
Should this repeat item actually be supplied again now?
See how timing, expected use, patient-held stock and medication changes can identify a repeat that may no longer be needed this cycle.
Medicines Resource Intelligence
If the medicine is needed, are we using the right clinically appropriate pathway?
Explore NHS and published evidence on ready-to-administer medicines, subcutaneous treatment and dose banding, then see what must still be measured locally before benefit is claimed.
Three different failure modes. One verification discipline.
Detect
Identify a medication mismatch, avoidable supply signal or resource opportunity.
Explain
Show the source, provenance and evidence behind the signal.
Own
Route the next action to the organisation or professional responsible.
Close
Require acknowledgement, reconciliation or clinically governed implementation.
Verify
Record safety, financial effect and genuinely reusable capacity separately.
The demos sit on evidence, not unsupported savings claims.
Unwarranted variation across acute hospitals
This was an efficiency opportunity, not £5 billion of cash proven to be wasted or recoverable today.Nursing capacity potentially released by ready-to-administer injectables
Modelled capacity release is not the same as reducing 4,000 posts or generating equivalent cash savings.GP appointments not attended
Missed appointments have many causes, including access barriers and health inequalities. They should not be framed simply as patient fault or all as avoidable.Unused medicines estimate still cited nationally
Do not present £300 million as a newly measured 2026 loss. The underlying national estimate is historic.Published NHS evidence can establish that a problem or intervention is real. It does not prove Sitora's local effect. That requires a governed pilot with observed outcomes and pre-agreed benefit definitions.
20 weeks to determine whether the opportunity is safely recoverable.
The next step is not a national rollout. It is a controlled pilot with baseline measurement, governed intervention and a Scale / Modify / Stop decision.
Net benefit, not headline savings.
Cash release, cost avoidance, capacity release and safety outcomes remain separate. Nothing enters a Resource Recovery Record merely because an algorithm identified an opportunity.